BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2559655)

  • 1. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
    Woods MG; Diana GD; Rogge MC; Otto MJ; Dutko FJ; McKinlay MA
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2069-74. PubMed ID: 2559655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
    Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
    Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice.
    McKinlay MA; Frank JA; Benziger DP; Steinberg BA
    J Infect Dis; 1986 Oct; 154(4):676-81. PubMed ID: 3745975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoxazoles with antipicornavirus activity.
    Diana GD; McKinlay MA; Brisson CJ; Zalay ES; Miralles JV; Salvador UJ
    J Med Chem; 1985 Jun; 28(6):748-52. PubMed ID: 2989517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WIN 51711, a new systematically active broad-spectrum antipicornavirus agent.
    McKinlay MA
    J Antimicrob Chemother; 1985 Sep; 16(3):284-6. PubMed ID: 4055541
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo antipicornavirus activity of some phenoxypyridinecarbonitriles.
    Kenny MT; Dulworth JK; Torney HL
    Antimicrob Agents Chemother; 1985 Dec; 28(6):745-50. PubMed ID: 2417545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts.
    Heim A; Pfetzing U; Müller G; Grumbach IM
    Antiviral Res; 1998 Jan; 37(1):47-56. PubMed ID: 9497072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954.
    See DM; Tilles JG
    Antimicrob Agents Chemother; 1992 Feb; 36(2):425-8. PubMed ID: 1318683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating.
    Diana GD; McKinlay MA; Otto MJ; Akullian V; Oglesby C
    J Med Chem; 1985 Dec; 28(12):1906-10. PubMed ID: 2999407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
    Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipicornavirus activity of tetrazole analogues related to disoxaril.
    Diana GD; Cutcliffe D; Volkots DL; Mallamo JP; Bailey TR; Vescio N; Oglesby RC; Nitz TJ; Wetzel J; Giranda V
    J Med Chem; 1993 Oct; 36(22):3240-50. PubMed ID: 8230114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral efficacy of WIN 51711 in mice infected with human poliovirus.
    McKinlay MA; Steinberg BA
    Antimicrob Agents Chemother; 1986 Jan; 29(1):30-2. PubMed ID: 3729333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
    Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
    Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan.
    Quaglia MG; Desideri N; Bossù E; Sestili I; Tomao P; Conti C; Orsi N
    Chirality; 1993; 5(5):356-8. PubMed ID: 8398593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipicornavirus activity of substituted phenoxybenzenes and phenoxypyridines.
    Markley LD; Tong YC; Dulworth JK; Steward DL; Goralski CT; Johnston H; Wood SG; Vinogradoff AP; Bargar TM
    J Med Chem; 1986 Mar; 29(3):427-33. PubMed ID: 3005578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of pleconaril against enteroviruses.
    Pevear DC; Tull TM; Seipel ME; Groarke JM
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2109-15. PubMed ID: 10471549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.
    Heinz BA; Rueckert RR; Shepard DA; Dutko FJ; McKinlay MA; Fancher M; Rossmann MG; Badger J; Smith TJ
    J Virol; 1989 Jun; 63(6):2476-85. PubMed ID: 2542566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
    Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
    Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of resistance to disoxaril in Coxsackie B1 virus-infected newborn mice.
    Nikolova I; Galabov AS
    Antiviral Res; 2003 Sep; 60(1):35-40. PubMed ID: 14516919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.